Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VRTX
VRTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRTX News
Vertex Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance
2d ago
seekingalpha
CRISPR Therapeutics: A Biotech Stock Poised for Growth
1d ago
Fool
CRISPR Therapeutics Shows Growth Potential
1d ago
NASDAQ.COM
CRISPR Therapeutics Stock Rises Despite Poor Q4 Earnings
1d ago
Fool
Wall Street Rebounds as Inflation Data Surprises
1d ago
Benzinga
Casgevy Therapy Revenue Shows Significant Growth
1d ago
Benzinga
Significant Stock Movements for Moderna and Others
1d ago
CNBC
Analysis of Vertex Pharmaceuticals Options Trading
1d ago
NASDAQ.COM
Vertex Pharmaceuticals Reports 10% Revenue Growth in Q4
2d ago
Benzinga
Multiple Companies Shine in After-Hours Trading
2d ago
CNBC
Vertex Pharmaceuticals' 2026 Revenue Guidance Meets Consensus Expectations
2d ago
seekingalpha
Vertex Pharmaceuticals Provides FY 2026 Financial Guidance
2d ago
seekingalpha
Tech Earnings Show Diverging Trends Amid Market Volatility
2d ago
Fool
Stock Movers: Cisco, AppLovin, Micron, Fastly, Equinix, Rollins, Novocure, and Others
3d ago
Barron's
Stocks Close Steady Following Robust Jobs Data
3d ago
Barron's
Vertex Pharmaceuticals Set to Release Q4 Earnings on February 12
3d ago
seekingalpha
Show More News
